Utilization of oncotype DX in node-negative, ER-positive breast cancer patients

被引：0
|
作者：
Patel, H. [1 ]
Hook, K. [1 ]
Kaplan, C. [1 ]
Davidson, R. [1 ]
DeMichele, A. [1 ]
Fox, K. R. [1 ]
Domchek, S. M. [1 ]
机构：
[1] Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11067
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of Oncotype DX on Treatment Decisions in ER-Positive, Node-Negative Breast Cancer with Histologic Correlation
    Biroschak, Julianne R.
    Schwartz, Gordon F.
    Palazzo, Juan P.
    Toll, Adam D.
    Brill, Kristin L.
    Jaslow, Rebecca J.
    Lee, Sun Yong
    [J]. BREAST JOURNAL, 2013, 19 (03): : 269 - 275
  • [2] Discordant classification and outcomes between Prosigna and Oncotype Dx Recurrence Score for ER-positive, HER2-negative, node-negative breast cancer
    Sestak, Ivana
    Ferree, Sean
    Shemesh, Itay
    Buckingham, Wesley
    Cuzick, Jack
    Dowsett, Mitchell
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [3] Oncotype Dx in Node-negative Breast Cancer: Our Experience
    Rizvi, S. A. J.
    Eldeeb, H.
    Soulsby, R.
    Taylor, A.
    Karina, M.
    [J]. CLINICAL ONCOLOGY, 2019, 31 (07) : E113 - E113
  • [4] Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
    Yasuto Naoi
    Kazuki Kishi
    Ryo Tsunashima
    Kenzo Shimazu
    Atsushi Shimomura
    Naomi Maruyama
    Masafumi Shimoda
    Naofumi Kagara
    Yosuke Baba
    Seung Jin Kim
    Shinzaburo Noguchi
    [J]. Breast Cancer Research and Treatment, 2013, 140 : 299 - 306
  • [5] Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
    Naoi, Yasuto
    Kishi, Kazuki
    Tsunashima, Ryo
    Shimazu, Kenzo
    Shimomura, Atsushi
    Maruyama, Naomi
    Shimoda, Masafumi
    Kagara, Naofumi
    Baba, Yosuke
    Kim, Seung Jin
    Noguchi, Shinzaburo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (02) : 299 - 306
  • [6] A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK
    Holt, S.
    Bertelli, G.
    Humphreys, I.
    Valentine, W.
    Durrani, S.
    Pudney, D.
    Rolles, M.
    Moe, M.
    Khawaja, S.
    Sharaiha, Y.
    Brinkworth, E.
    Whelan, S.
    Jones, S.
    Bennett, H.
    Phillips, C. J.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (11) : 2250 - 2258
  • [7] A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK
    S Holt
    G Bertelli
    I Humphreys
    W Valentine
    S Durrani
    D Pudney
    M Rolles
    M Moe
    S Khawaja
    Y Sharaiha
    E Brinkworth
    S Whelan
    S Jones
    H Bennett
    C J Phillips
    [J]. British Journal of Cancer, 2013, 108 : 2250 - 2258
  • [8] Comparison of risk stratification of ER-positive, node-negative breast cancer patients by Oncotype DX versus molecular grade index and HOXB13/IL17BR ratio
    Sgroi, D.
    Hameed, O.
    Hattab, E.
    Chang, B.
    Moulis, S.
    Steffel, L.
    Salunga, R.
    Ma, X.
    Erlander, M.
    Goss, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia
    Sakata, Shinichiro
    Cronk, Michelle
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (01) : 94 - 95
  • [10] Oncotype Dx assay in BRCA positive ER positive breast cancer patients
    Halpern, N.
    Sonnenblick, A.
    Kaduori, L.
    Uziely, B.
    Goldberg, Y.
    Katz, D.
    AlIweis, T.
    Divinsky, L.
    Merlet, I.
    Maly, B.
    Sagi, M.
    Hamburger, T.
    Carmon, E.
    Peretz, T.
    [J]. CANCER RESEARCH, 2013, 73
12345